Literature DB >> 23800820

Differential phenotypic behaviors of human degenerative nucleus pulposus cells under normoxic and hypoxic conditions: influence of oxygen concentration during isolation, expansion, and cultivation.

Shu-Hua Yang1, Ming-Hsiao Hu, Yuan-Hui Sun, Feng-Huei Lin.   

Abstract

BACKGROUND CONTEXT: Intervertebral discs (IVDs) are the largest avascular structures in the body; therefore, cells within these discs might be adapted to low-oxygen conditions. Although it has been demonstrated that a low oxygen concentration could promote synthesis of the extracellular matrix by IVD cells in the in vitro culture, isolation, expansion, and cultivation of IVD cells under classical tissue culture O2 saturation could still be detrimental.
PURPOSE: To investigate the phenotypic differences between human degenerative nucleus pulposus (NP) cells during isolation and expansion under normoxic (Nx: 21% O2) or hypoxic (Hx: 3.5% O2) conditions. STUDY
DESIGN: We investigated in vitro isolation, expansion, and cultivation of human NP cells.
METHODS: Human NP tissue samples were obtained from patients who underwent lumbar disc surgeries. Nucleus pulposus cells were then isolated, expanded, and cultivated under normoxic or hypoxic conditions. To determine whether the effects of normoxic expansion are reversible, another group of cells was isolated and expanded in normoxic conditions and then cultivated under hypoxic conditions (Nx→Hx group). Cellular proliferation, RNA expression of selected genes, and immunohistochemical staining were performed to evaluate the phenotypic behaviors of human NP cells under different conditions.
RESULTS: Expressions of Type II collagen and aggrecan in the Nx→Hx group were significantly higher than those in the normoxic group but were significantly lower than those in the hypoxic group. The normoxic group showed higher expression of matrix metalloproteinase (MMP)-2 and MMP-13 than did the other groups. Expression levels of hypoxia-inducible factors (HIFs) were significantly higher in the normoxic groups; however, a greater degree of HIF-1α staining was found in the hypoxic group, whereas a greater degree of HIF-2α staining was found in the normoxic group.
CONCLUSIONS: Human degenerative NP cells isolated, expanded, and cultivated in hypoxic conditions could better preserve the cells' regenerative potential. Compromised properties that were observed during isolation and expansion under normoxic conditions could only be partially rescued by later hypoxic cultivation. The superior phenotypic behaviors of human NP cells under hypoxia may be related to higher HIF-1α production and lower HIF-2α production. Cells that are isolated, expanded, and cultivated under hypoxic conditions may show better regenerative results when transplanted; therefore, the isolation and expansion processes of human degenerative NP cells should be managed in a hypoxic environment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell culture; Hypoxia; Nucleus pulposus

Mesh:

Substances:

Year:  2013        PMID: 23800820     DOI: 10.1016/j.spinee.2013.05.025

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  10 in total

1.  Extracellular matrix production by nucleus pulposus and bone marrow stem cells in response to altered oxygen and glucose microenvironments.

Authors:  Syeda M Naqvi; Conor T Buckley
Journal:  J Anat       Date:  2015-04-25       Impact factor: 2.610

2.  Biomimetic nucleus pulposus scaffold created from bovine caudal intervertebral disc tissue utilizing an optimal decellularization procedure.

Authors:  Christopher Fernandez; Alan Marionneaux; Sanjitpal Gill; Jeremy Mercuri
Journal:  J Biomed Mater Res A       Date:  2016-08-19       Impact factor: 4.396

3.  Long non-coding RNA HOTAIR modulates intervertebral disc degenerative changes via Wnt/β-catenin pathway.

Authors:  Shengfeng Zhan; Kun Wang; Yu Song; Shuai Li; Huipeng Yin; Rongjin Luo; Zhiwei Liao; Xinghuo Wu; Yukun Zhang; Cao Yang
Journal:  Arthritis Res Ther       Date:  2019-09-03       Impact factor: 5.156

4.  The potential role and trend of HIF‑1α in intervertebral disc degeneration: Friend or foe? (Review).

Authors:  Yongjin Li; Shen Liu; Dayu Pan; Baoshan Xu; Xuewu Xing; Hengxing Zhou; Bin Zhang; Suzhe Zhou; Guangzhi Ning; Shiqing Feng
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

5.  Hyperosmolar expansion medium improves nucleus pulposus cell phenotype.

Authors:  Lisanne T Laagland; Frances C Bach; Laura B Creemers; Christine L Le Maitre; Deepani W Poramba-Liyanage; Marianna A Tryfonidou
Journal:  JOR Spine       Date:  2022-08-18

6.  The Cellular Composition of Bovine Coccygeal Intervertebral Discs: A Comprehensive Single-Cell RNAseq Analysis.

Authors:  Martina Calió; Benjamin Gantenbein; Marcel Egli; Lucy Poveda; Fabian Ille
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

7.  LDHA-Mediated Glycolytic Metabolism in Nucleus Pulposus Cells Is a Potential Therapeutic Target for Intervertebral Disc Degeneration.

Authors:  Longxi Wu; Jieliang Shen; Xiaojun Zhang; Zhenming Hu
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

8.  Wnt signaling activates Shh signaling in early postnatal intervertebral discs, and re-activates Shh signaling in old discs in the mouse.

Authors:  Tamara Winkler; Eric J Mahoney; Debora Sinner; Christopher C Wylie; Chitra Lekha Dahia
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

9.  Link-N: The missing link towards intervertebral disc repair is species-specific.

Authors:  Frances C Bach; Lisanne T Laagland; Michael P Grant; Laura B Creemers; Keita Ito; Björn P Meij; Fackson Mwale; Marianna A Tryfonidou
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

10.  Omega-3 Fatty Acid Supplementation Reduces Intervertebral Disc Degeneration.

Authors:  Zachary NaPier; Linda E A Kanim; Yasaman Arabi; Khosrowdad Salehi; Barry Sears; Mary Perry; Sang Kim; Dmitriy Sheyn; Hyun W Bae; Juliane D Glaeser
Journal:  Med Sci Monit       Date:  2019-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.